...
首页> 外文期刊>Research journal of pharmacy and technology >In-vitro cell line Models and Assay methods to study the Anti-diabetic Activity
【24h】

In-vitro cell line Models and Assay methods to study the Anti-diabetic Activity

机译:体外细胞系模型和测定方法研究抗糖尿病活性

获取原文
获取原文并翻译 | 示例
           

摘要

Cases of Diabetes mellitus around the world are increasing day by day. It has been predicted that India, China and United States will be having the largest number of diabetic patients by 2030. Therefore, the anti-diabetic study is attracted a huge number of scientists and various in-vitro and in-vivo models has been developed for anti-diabetic study. In drug development, the in-vitro techniques are an important method of confirming a particular biological activity of a compound before animal experiments. In vitro cell lines are alternative to animal models to study the particular activity of dmgs. To produce more reproducible results, the in-vitro cell lines from clonal cells, cell lines are used. Characteristics of cell lines are constantly changing because of continuous growth of cells without any limits being its disadvantage. This review attempts to bring together all reported in-vitro cell line models to study the anti-diabetic activity. These cell lines may prove essential for the development of new drugs for the treatment of diabetes mellitus. Study of anti-diabetics activity of various agents in cell line models is important for improving the knowledge and in providing a clear understanding of pathogenesis leading to the discovery of new therapies for the disease. Many cell lines have been discovered in past few decades for the in-vitro studies involving diabetes mellitus. The generation of cell lines may bedecreased the number of animals used for in-vivo studies. Using cell lines for anti-diabetic studies also put aside the painful techniques in the in-vivo studies.
机译:世界各地的糖尿病病例日益增长。据预测,今年2030年,印度,中国和美国将拥有最多糖尿病患者患者。因此,抗糖尿病研究被吸引了大量的科学家,并且已经开发出各种体外和体内模型用于抗糖尿病研究。在药物开发中,体外技术是在动物实验之前确认化合物的特定生物活性的重要方法。体外细胞系是动物模型的替代,以研究DMG的特定活性。为了产生更多可重复的结果,使用来自克隆细胞的体外细胞系,使用细胞系。由于细胞的连续生长而没有任何限制的缺点,细胞系的特征是不断变化的。本综述试图将所有报告的体外细胞系模型汇集在一起​​以研究抗糖尿病活性。这些细胞系可能证明是对治疗糖尿病的新药的发展是必需的。细胞系模型中各种药剂的抗糖尿病活性的研究对于改善知识是重要的,并对发病机制的明确了解,这是对疾病的新疗法发现的发病机制。过去几十年来发现了许多细胞系,用于涉及糖尿病的体外研究。细胞系的产生可以欺骗用于体内研究的动物的数量。使用细胞系进行抗糖尿病研究,还抛开了体内研究中的痛苦技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号